Profound Medical Corp. Files 6-K with Press Release
Ticker: PROF · Form: 6-K · Filed: Dec 2, 2024 · CIK: 1628808
| Field | Detail |
|---|---|
| Company | Profound Medical Corp. (PROF) |
| Form Type | 6-K |
| Filed Date | Dec 2, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, press-release, sec-report
TL;DR
Profound Medical Corp. dropped a 6-K with a press release on Dec 2nd, check Exhibit 99.1 for news.
AI Summary
Profound Medical Corp. filed a Form 6-K on December 2, 2024, to report a press release dated the same day. The filing is made under the Securities Exchange Act of 1934 and indicates the company will file annual reports under Form 40-F. The press release itself is attached as Exhibit 99.1.
Why It Matters
This filing indicates Profound Medical Corp. is providing updated information to the SEC, likely containing material news relevant to investors.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) to submit a press release, not indicating any immediate financial distress or significant operational change.
Key Players & Entities
- Profound Medical Corp. (company) — Registrant
- December 2, 2024 (date) — Filing and Press Release Date
- Form 6-K (document) — Filing Type
- Form 40-F (document) — Annual Report Filing Indicator
- Exhibit 99.1 (document) — Attached Press Release
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is filed to report a press release dated December 2, 2024, as required by the Securities Exchange Act of 1934.
What is the filing date of this report?
The filing date is December 2, 2024.
Which exhibit is attached to this filing?
Exhibit 99.1, a press release dated December 2, 2024, is attached to this filing.
Under which form will Profound Medical Corp. file its annual reports?
Profound Medical Corp. indicates it will file its annual reports under Form 40-F.
What is the principal executive office address of Profound Medical Corp.?
The principal executive office is located at 2400 Skymark Avenue, Unit 6, Mississauga, Ontario L4W 5K5.
Filing Stats: 165 words · 1 min read · ~1 pages · Grade level 12.9 · Accepted 2024-12-02 07:45:04
Filing Documents
- f6k_120224.htm (6-K) — 4KB
- exh_991.htm (EX-99.1) — 14KB
- 0001171843-24-006641.txt ( ) — 20KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. PROFOUND MEDICAL CORP. (Registrant) Date: December 2, 2024 /s/ Rashed Dewan Rashed Dewan Chief Financial Officer